Head of Oral Drug Products; Vice President

Oral Drug Product Leader

Leads the global Oral Drug Product organization and delivery of oral drug product development from early phase through commercialization and lifecycle management.

Sets strategy and builds capabilities for robust, scalable oral formulations and manufacturing processes, including tech transfer and process validation/PPQ readiness.

Partners with Pharm Sci functions and key stakeholders (GSQ, Quality, Regulatory CMC, Commercial, R&D, Supply Chain) and external partners to deliver high-quality oral products.

Owns the global Oral Drug Product strategy and operating model to deliver phase-appropriate, scalable, and robust oral dosage forms across the pipeline and lifecycle.

Accountable for oral drug product design and development from pre-formulation through clinical and commercial readiness, including selection of dosage form, excipients, and process pathway consistent with target product profile.

Leads development of robust oral formulations and control strategies using QbD principles, including identification of CQAs, CPPs, design space (where appropriate), and lifecycle management plans.

Oversees oral process development and scale-up (e.g., blending, granulation, compression, coating, encapsulation, hot-melt extrusion, spray drying, 3D/continuous manufacturing where applicable), including tech transfer to internal sites and/or CMOs through PPQ and commercialization.

Accountable for CMC deliverables for global submissions (IND/CTA/NDA/MAA variations), ensuring high-quality module content, responses, and inspection readiness for oral drug products.

Establishes platform approaches and standards for oral dosage forms (e.g., enabling formulations, pediatric/geriatric considerations, modified release strategies) to increase reuse and reduce cycle time.

Drives science- and data-based selection and management of CMOs/CDMOs for oral products, including governance, performance, supply risk mitigation, and technical oversight.

Partners effectively with Analytical, Drug Substance, Device (as needed), Regulatory CMC, Quality/GSQ, Supply Chain, and Commercial to assure robust product and process strategies through launch and beyond.

Builds a high-performing global organization; develops talent, ensures appropriate resourcing across programs, and drives a culture of innovation, compliance, and continuous improvement.

Deep expertise in oral solid dose and oral enabling technologies (BCS-driven strategy, solubility/permeability enhancement, amorphous dispersions, salt/co-crystal selection interface, lipid-based formulations where appropriate).

Strong experience in oral pre-formulation and biopharmaceutics-facing formulation design (dissolution, supersaturation, precipitation risk, food effect considerations, IVIVC/biorelevant methods alignment).

Demonstrated capability in oral process development, scale-up, and manufacturing science (unit operations, PAT, continuous manufacturing understanding, process robustness, control strategy).

Experience with global GMP and oral product regulatory expectations, including CMC submission strategy, lifecycle management, and inspection readiness.

Proven leadership in tech transfer to internal sites and CMOs, including process validation/PPQ execution and commercial troubleshooting.

Knowledge of packaging/CCS considerations for oral products (e.g., blister vs bottle, moisture/oxygen/light protection, stability strategy alignment).

Strategic thinking, facilitative leadership.

Executive leadership presence and confidence.

Enterprise level leadership with the ability to inspire, motivate and drive results.

Excellent communicator, able to persuasively convey both ideas and data, verbally and in writing.

Ability to assemble and manage a diverse and high performing team.

Demonstrated ability to lead teams across functions, regions and cultures.

Ability to distill complex issues and ideas down to simple comprehensibility.

Proven skills as leader who can engender credibility and confidence within and outside the company.

Embraces and demonstrates a diversity and inclusion mindset and role models these behaviors for the organization.

Broad decision-making responsibilities:

Ability to make highly complex decisions that impact the enterprise.

Ability to seek diverse input from multiple constituents and stakeholders to drive innovative solutions.

Ability to incorporate feedback and ensure decisions are made transparently and swiftly to yield flawless execution.

Accountable for designing and implementing vision and strategy for designated scope.

Effectively navigates the changing external and internal environment and leads others through change by creating and inspiring an engaging and inclusive workplace.

Ability to effectively implement R&D's partnership strategy.

Effectively represent Takeda in high-level negotiations with the ability to resolve conflict in a constructive manner.

Ability to build strong partnerships and drive role clarity with other interfacing Takeda functions, including but not limited to…